8:42 AM ET
8-K
Business Update
Phio Pharmaceuticals Business Update
Phio Pharmaceuticals successfully completed its first commercial-scale cGMP batch of PH-762 drug substance, a key manufacturing milestone. This achievement validates the company's supply chain readiness and supports the planned initiation of a Phase 2b clinical trial in the first quarter of 2027.